284 related articles for article (PubMed ID: 6739224)
1. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
László FA; Csáti S; Baláspiri L; Manning M
Acta Med Hung; 1984; 41(1):65-73. PubMed ID: 6739224
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
[TBL] [Abstract][Full Text] [Related]
3. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
László FA; Baláspiri L
Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
[TBL] [Abstract][Full Text] [Related]
4. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
[TBL] [Abstract][Full Text] [Related]
5. [The effect of vasopressin analogs on water metabolism].
László F; Laczi F; Julesz J; Baláspiri L
Z Gesamte Inn Med; 1983 Nov; 38(22):248-50. PubMed ID: 6666181
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
Mann WA; Stassen F; Huffman W; Kinter LB
J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
[TBL] [Abstract][Full Text] [Related]
7. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
Mah SC; Hofbauer KG
J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
[TBL] [Abstract][Full Text] [Related]
10. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
11. Discovery and therapeutic utility of vasopressin antagonists in rats.
Kinter LB; Dytko G; Ashton D; McDonald J; Huffman W; Stassen F
J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S36-43. PubMed ID: 2434770
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
Varga C; Somlai C; Baláspiri L; László FA
Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
[TBL] [Abstract][Full Text] [Related]
13. A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats.
Tang AH; Ho PM
Life Sci; 1988; 43(5):399-403. PubMed ID: 3398706
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
15. Effect of the aquaretic vasopressin antagonists d(CH2)5[D-Tyr(Et)2-Val4]AVP and d(CH2)5[D-Phe2-Phe4]AVP on urine production in healthy dogs.
van Oosterhout IC; Rijnberk A; Mol JA
Horm Metab Res; 1992 May; 24(5):244-5. PubMed ID: 1398466
[No Abstract] [Full Text] [Related]
16. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
László FA; Laczi F; Janáky T; Baláspiri L
Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism.
Snijdewint FG; Boer GJ
Neurobehav Toxicol Teratol; 1986; 8(3):213-7. PubMed ID: 3736748
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.
Albrightson-Winslow CR; Caldwell N; Brooks DP; Huffman WF; Stassen FL; Kinter LB
J Pharmacol Exp Ther; 1989 May; 249(2):366-71. PubMed ID: 2524585
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cerebral edema by the vasopressin antagonist d(CH2)5D-Ile2Ile4Ala9AVP in rats with experimental subarachnoid hemorrhage.
László FA; Varga C; Baláspiri L
Ann N Y Acad Sci; 1993 Jul; 689():627-9. PubMed ID: 8373062
[No Abstract] [Full Text] [Related]
20. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
